Open AccessEfficacy of Favipiravir in the Treatment of Moderate COVID-19 Patients: A Randomized, Open-label, Controlled Clinical Trial
Author(s) -
Shabnam Tehrani,
Davood Yadegarynia,
Afshin BAGHERZADE,
Latif Gachkar,
Amirreza Keyvanfar
Publication year - 2022
Publication title -
mediterranean journal of infection microbes and antimicrobials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.121
H-Index - 1
ISSN - 2147-673X
DOI - 10.4274/mjima.galenos.2022.2022.30
Subject(s) - favipiravir , covid-19 , randomized controlled trial , medicine , open label , off label use , clinical trial , virology , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom